Status:
UNKNOWN
Spinal Fusions Steroid Study
Lead Sponsor:
University of Texas at Austin
Conditions:
Spinal Fusion
Eligibility:
All Genders
10-18 years
Phase:
EARLY_PHASE1
Brief Summary
Current efforts to improve pain alleviation focus on non-opioid pharmaceuticals. Intravenous perioperative corticosteroid administration has been suggested as an alternative method for post-operative ...
Eligibility Criteria
Inclusion
- Meets operative criteria for posterior spinal instrumented fusion for AIS
- Parental consent
Exclusion
- Revision procedure
- Other associated conditions which may alter the postoperative course
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05287035
Start Date
July 1 2023
End Date
July 1 2025
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dell Children's Medical Center
Austin, Texas, United States, 78731